Eligible patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases52

Neoplasm Recurrence, Local Lung Neoplasms Neutropenia Recurrence Disease Progression Adenocarcinoma Carcinoma, Non-Small-Cell Lung Breast Neoplasms Peritoneal Neoplasms Colorectal Neoplasms Brain Stem Neoplasms Neoplasm Metastasis Thrombocytopenia Fallopian Tube Neoplasms Carcinoma, Small Cell Nausea Brain Neoplasms Neoplasms Lymphoma, Non-Hodgkin Stroke Carcinoma, Squamous Cell Ovarian Neoplasms Hematologic Diseases Bone Neoplasms Thoracic Neoplasms Sarcoma Lymphatic Metastasis Vomiting Leukopenia Prostatic Neoplasms Acute Disease Head and Neck Neoplasms Rectal Neoplasms Myocardial Infarction Neoplasms, Germ Cell and Embryonal Hodgkin Disease Pleural Neoplasms Anorexia Carcinoma, Transitional Cell Biliary Tract Neoplasms Fatigue Urologic Neoplasms Drug-Related Side Effects and Adverse Reactions Rhabdomyosarcoma Agranulocytosis Esophageal Neoplasms Heart Failure Soft Tissue Neoplasms Melanoma Anemia Multiple Myeloma Urinary Bladder Neoplasms

Chemicals and Drugs64

Cisplatin Vincristine Doxorubicin Cyclophosphamide Etoposide Paclitaxel Antineoplastic Agents Fluorouracil Vinblastine Ifosfamide Deoxycytidine Carboplatin Prednisone Dacarbazine Methotrexate Bleomycin Antimetabolites, Antineoplastic Organoplatinum Compounds Taxoids Antibodies, Monoclonal, Humanized Antineoplastic Agents, Phytogenic Procarbazine Vindesine Camptothecin Leucovorin Antineoplastic Agents, Alkylating Lomustine Epirubicin Antibodies, Monoclonal Mitoxantrone Mesna Fibrinolytic Agents Antibiotics, Antineoplastic Antineoplastic Agents, Hormonal Mitomycin Quinazolines Cytarabine Mechlorethamine Carmustine Topotecan Melphalan Levamisole Anticoagulants Oxonic Acid Niacinamide Placebos Warfarin Drug Combinations Epothilones Granulocyte Colony-Stimulating Factor Androgen Antagonists Benzenesulfonates Phenylurea Compounds Aspirin Thalidomide Tamoxifen Interferon-alpha Guanine Floxuridine Tegafur Antibodies, Monoclonal, Murine-Derived Tissue Plasminogen Activator Platelet Aggregation Inhibitors Glutamates

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Survival Analysis Disease-Free Survival Combined Modality Therapy Prospective Studies Patient Selection Survival Rate Follow-Up Studies Infusions, Intravenous Neoplasm Staging Retrospective Studies Feasibility Studies Chemotherapy, Adjuvant Remission Induction Kaplan-Meier Estimate Prognosis Double-Blind Method Maximum Tolerated Dose Research Design Questionnaires Clinical Protocols Risk Factors Multicenter Studies as Topic Salvage Therapy Radiotherapy, Adjuvant Administration, Oral Pilot Projects Cohort Studies Radiotherapy Multivariate Analysis Treatment Failure Neoadjuvant Therapy Clinical Trials, Phase IV as Topic Risk Assessment Drug Therapy, Combination Radiotherapy Dosage Proportional Hazards Models Chemoradiotherapy Thrombolytic Therapy Randomized Controlled Trials as Topic Ambulatory Care Logistic Models Palliative Care Chi-Square Distribution Administration, Intravenous Severity of Illness Index Registries Clinical Trials as Topic Mass Screening Predictive Value of Tests Dose Fractionation Transplantation, Autologous Probability Colonoscopy Karnofsky Performance Status Patient Discharge Brachytherapy Confidence Intervals Statistics, Nonparametric Cross-Sectional Studies Hospitalization Drug Evaluation Clinical Trials, Phase I as Topic Analysis of Variance Sample Size Odds Ratio Cranial Irradiation Injections, Intravenous Electronic Health Records Placebos Clinical Trials, Phase III as Topic Radiotherapy, Conformal Sensitivity and Specificity Prevalence Decision Support Techniques Random Allocation Postoperative Care Incidence Hospital Mortality

Psychiatry and Psychology5

Patient Compliance Medication Adherence Treatment Refusal Decision Making Physician-Patient Relations

Phenomena and Processes7

Time Factors Maximum Tolerated Dose Dose-Response Relationship, Drug Chi-Square Distribution Probability Odds Ratio Sensitivity and Specificity

Disciplines and Occupations4

Research Design Outcome Assessment (Health Care)Family Practice General Practice

Anthropology, Education, Sociology and Social Phenomena4

Quality of Life Patient Education as Topic Treatment Refusal Informed Consent

Technology, Industry, Agriculture1

Quality Improvement

Humanities1

Quality of Life

Information Science9

Survival Rate Questionnaires Reminder Systems Registries Radiotherapy, Conformal Prevalence Decision Support Techniques Incidence Hospital Mortality

Named Groups4

Outpatients Terminally Ill Inpatients Survivors

Health Care88

Treatment Outcome Survival Analysis Disease-Free Survival Prospective Studies Patient Selection Survival Rate Follow-Up Studies Retrospective Studies Feasibility Studies Kaplan-Meier Estimate Guideline Adherence Double-Blind Method Patient Compliance Eligibility Determination Questionnaires Clinical Protocols Risk Factors Multicenter Studies as Topic Pilot Projects Practice Guidelines as Topic Patient Satisfaction Cohort Studies Intention to Treat Analysis Primary Health Care Multivariate Analysis Treatment Failure Clinical Trials, Phase IV as Topic Emergency Service, Hospital Risk Assessment Quality Indicators, Health Care Outcome Assessment (Health Care)Proportional Hazards Models Physician's Practice Patterns Randomized Controlled Trials as Topic Age Factors Ambulatory Care Logistic Models Patient Education as Topic Cost-Benefit Analysis Palliative Care Chi-Square Distribution Severity of Illness Index Registries Clinical Trials as Topic Quality Improvement Mass Screening Predictive Value of Tests Medication Adherence Outpatient Clinics, Hospital Patient Acceptance of Health Care Quality of Health Care Probability Hospitals, University Selection Bias Patient Participation Karnofsky Performance Status Outcome and Process Assessment (Health Care)Patient Discharge Confidence Intervals Treatment Refusal Quality Assurance, Health Care Statistics, Nonparametric Cross-Sectional Studies Referral and Consultation Hospitalization Clinical Trials, Phase I as Topic Safety Medical Audit Analysis of Variance Sample Size Odds Ratio Emergency Medical Services Process Assessment (Health Care)Clinical Trials, Phase III as Topic Hospitals, Community Sensitivity and Specificity Drug Utilization Patient Care Team Ambulatory Care Facilities Prevalence Informed Consent Random Allocation Postoperative Care Incidence Hospital Mortality Hospitals, Teaching Triage Physician-Patient Relations

Geographicals6

United States Ontario Canada Great Britain Michigan Netherlands

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Survival Analysis Disease-Free Survival Combined Modality Therapy Prospective Studies Cisplatin Patient Selection Vincristine Survival Rate Doxorubicin Follow-Up Studies Infusions, Intravenous Neoplasm Staging Time Factors Retrospective Studies Cyclophosphamide Feasibility Studies Etoposide Neoplasm Recurrence, Local Paclitaxel Antineoplastic Agents Fluorouracil Vinblastine Ifosfamide Chemotherapy, Adjuvant Remission Induction Quality of Life Deoxycytidine Lung Neoplasms Kaplan-Meier Estimate Carboplatin Prognosis Prednisone Dacarbazine Guideline Adherence Neutropenia Double-Blind Method Recurrence Maximum Tolerated Dose Research Design Patient Compliance Eligibility Determination Questionnaires Methotrexate Disease Progression Bleomycin Adenocarcinoma Clinical Protocols Risk Factors Antimetabolites, Antineoplastic Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug Multicenter Studies as Topic Breast Neoplasms Organoplatinum Compounds Salvage Therapy Taxoids Radiotherapy, Adjuvant Administration, Oral Antibodies, Monoclonal, Humanized Pilot Projects Antineoplastic Agents, Phytogenic Procarbazine United States Practice Guidelines as Topic Peritoneal Neoplasms Patient Satisfaction Cohort Studies Intention to Treat Analysis Primary Health Care Vindesine Radiotherapy Multivariate Analysis Treatment Failure Neoadjuvant Therapy Clinical Trials, Phase IV as Topic Emergency Service, Hospital Camptothecin Colorectal Neoplasms Leucovorin Risk Assessment Quality Indicators, Health Care Drug Therapy, Combination Radiotherapy Dosage Outcome Assessment (Health Care)Brain Stem Neoplasms Reminder Systems Antineoplastic Agents, Alkylating Neoplasm Metastasis Lomustine Thrombocytopenia Fallopian Tube Neoplasms Proportional Hazards Models Chemoradiotherapy Epirubicin Carcinoma, Small Cell Thrombolytic Therapy Physician's Practice Patterns

No FAQ available that match "eligible patients"